__timestamp | HUTCHMED (China) Limited | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 72049000 | 60987000 |
Thursday, January 1, 2015 | 110777000 | 125542000 |
Friday, January 1, 2016 | 156328000 | 210460000 |
Sunday, January 1, 2017 | 175820000 | 275119000 |
Monday, January 1, 2018 | 143944000 | 409539000 |
Tuesday, January 1, 2019 | 160152000 | 547758000 |
Wednesday, January 1, 2020 | 188519000 | 736300000 |
Friday, January 1, 2021 | 258234000 | 904200000 |
Saturday, January 1, 2022 | 311103000 | 1080300000 |
Sunday, January 1, 2023 | 384447000 | 1262200000 |
Monday, January 1, 2024 | 1530500000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Over the past decade, Vertex Pharmaceuticals Incorporated and HUTCHMED (China) Limited have showcased contrasting trajectories in their cost of revenue. From 2014 to 2023, Vertex's cost of revenue surged by over 1,900%, reflecting its aggressive expansion and investment in cutting-edge therapies. In contrast, HUTCHMED's cost of revenue increased by approximately 430%, indicating a more measured growth strategy.
In 2014, both companies started with similar cost bases, but by 2023, Vertex's cost of revenue was more than three times that of HUTCHMED. This disparity highlights Vertex's commitment to scaling its operations, while HUTCHMED has maintained a steady, albeit slower, growth pace. These trends offer valuable insights into each company's strategic priorities and market positioning.
Pfizer Inc. vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs HUTCHMED (China) Limited
Cost of Revenue Trends: Pharming Group N.V. vs HUTCHMED (China) Limited
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Travere Therapeutics, Inc.